Refractive Consequences of Epiretinal Membrane Surgery
EPIREF
1 other identifier
interventional
62
1 country
1
Brief Summary
Epiretinal membrane is treated with vitrectomy and peeling. Afterwards cataract is usually developed, which requires a cataract surgery. The aim of this study is to investigate the refractive consequences of surgery for Epiretinal membrane and cataract. Investigators investigate the sequence of surgery in patients having surgery for Epiretinal membrane and cataract in a prospective clinically randomized intervention trial. Patients are randomized to 1) start with vitrectomy, 2) start with cataract surgery, 3) combined surgery. Investigators want to find the sequence of surgery that gives the most optimal refractive result, the most stabile intraocular lens, and the minimal loss of corneal endothelial cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 27, 2015
CompletedFirst Posted
Study publicly available on registry
April 10, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedNovember 10, 2016
November 1, 2016
2.4 years
March 27, 2015
November 9, 2016
Conditions
Outcome Measures
Primary Outcomes (3)
Refractive Error
Prediction error of intraocular lens calculation (measured in diopters)
One year
Corneal endothelial count
measured in number of cells per square millimeter (mm2)
One year
Macula anatomy
Macula-anatomy success of surgery, i.e. the postoperative decrease of macula thickness or postoperative macular oedema. Measured in millimeter.
One year
Secondary Outcomes (2)
Anterior Chamber Depth
One year
Axial length
One year
Study Arms (3)
Start cataract
ACTIVE COMPARATORPatients start having cataract surgery. After one month they undergo vitrectomy
start vitrectomy
ACTIVE COMPARATORPatients start having vitrectomy. After one month they undergo cataract surgery.
combined surgery
ACTIVE COMPARATORCombined cataract surgery and vitrectomy at the same time
Interventions
Eligibility Criteria
You may qualify if:
- A diagnosis of Epiretinal membrane,
- visual complaints consistent with Epiretinal membrane,
- age more than 50 years,
- refraction less than ± 5 diopters and astigmatism less than 3 diopters,
- indication for vitrectomy is only Epiretinal membrane.
You may not qualify if:
- Previous intraocular surgery or laser-refractive procedure.
- Use of intraocular gas tamponade during the vitrectomy.
- Intraoperative manipulation of the intraocular lens.
- Serious complications (endophthalmitis, vitreous haemorrhage or retinal detachment).
- History of previous head or ocular trauma.
- Sulcus fixation of intraocular lens
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye Department Glostrup Hospital
Glostrup Municipality, DK, 2600, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hassan Hamoudi, MD
Eye Department Glostrup Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 27, 2015
First Posted
April 10, 2015
Study Start
May 1, 2014
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
November 10, 2016
Record last verified: 2016-11